Clinical Trial Update: Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetics study of oral 2-Deoxy-D-Glucose (2DG) in adults with epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Seizure

Drugs mentioned

• 2-Deoxy-D-glucose (2-Deoxy-D-glucose)

Snippet

Sponsor: University of Virginia | Conditions: Epilepsy; Seizure | Phase 2 | Status: COMPLETED